Open
非病毒基因改造細胞療法的開發，研發治療實體腫瘤CAR-T細胞免疫療法新藥，具專利保護、更安全、成本低廉之非病毒基因體改照平台(治療淋巴癌血液腫瘤)。
Using CAR-T as the first focus to demonstrate the power of our virus-free Quantum Engine™ for cell engineering, the firm has established Quantum CART™ (qCART™) system which is tailored specifically for engineering and production of efficacious therapies to overcome CAR-T obstacles, including those for treating solid cancers.
Using CAR-T as the first focus to demonstrate the power of our virus-free Quantum Engine™ for cell engineering, the firm has established Quantum CART™ (qCART™) system which is tailored specifically for engineering and production of efficacious therapies to overcome CAR-T obstacles, including those for treating solid cancers.